PUBLISHER: 360iResearch | PRODUCT CODE: 1499437
PUBLISHER: 360iResearch | PRODUCT CODE: 1499437
[197 Pages Report] The Femtech Market size was estimated at USD 35.91 billion in 2023 and expected to reach USD 40.85 billion in 2024, at a CAGR 14.47% to reach USD 92.51 billion by 2030.
Femtech is a category of software, diagnostics, products, and services that use technology for focusing on women's health. This includes various applications such as fertility solutions, period-tracking apps, pregnancy and nursing care, reproductive system health, and general wellness. The goal of femtech is to leverage technology to address women's unique health challenges and provide innovative solutions tailored to women's health and wellbeing needs. The high prevalence of women's health issues, such as menstrual disorders, fertility issues, and menopause-related problems, is driving the need for innovative solutions provided by the femtech market. However, cybersecurity concerns significantly hinder the growth of the femtech market as the fear of data breaches and unauthorized access to sensitive health information deters consumers and healthcare providers from adopting femtech solutions. The ongoing innovations in femtech products and services, coupled with the increasing availability of customized products, offers an opportunity for the expansion of the femtech market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 35.91 billion |
Estimated Year [2024] | USD 40.85 billion |
Forecast Year [2030] | USD 92.51 billion |
CAGR (%) | 14.47% |
Regional Insights
In the Americas, particularly in North America, the market benefits from well-established healthcare infrastructure and higher consumer awareness, driving robust demand for innovations, such as fertility tracking apps, wearable health devices, and telehealth services. Companies in this region capitalize on the substantial investment climate and active venture capital presence. The Asia-Pacific region is showcasing market growth fueled by increasing digital adoption, urbanization, and rising awareness of women's health issues. China's advanced tech infrastructure and large population foster mobile health apps and wearables for reproductive health. Japan's aging population and demand for high-quality health products fuel fertility treatments and wellness tracking investments. Meanwhile, India's market thrives with affordable mobile applications and telehealth services for women's health. In the EMEA region, the femtech market is expanding, supported by progressive healthcare policies and a growing focus on gender-specific medical research. European countries, in particular, showcase a favorable environment for femtech startups due to supportive regulations and funding opportunities. The market in the Middle East is gradually growing, with rising interest in fertility treatments and maternal care as awareness grows. Africa's femtech market is emerging, focusing on accessible reproductive health education, menstrual hygiene products, and mobile health services to address healthcare access challenges.
Market Insights
The market dynamics represent an ever-changing landscape of the Femtech Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Femtech Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Femtech Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Strategic Merger Strengthens Keleya's Position in FemTech Market
In a strategic move to enhance support for pregnant women and new mothers, digital platforms keleya and Kinderheldin are merging to operate collectively under the keleya brand. This merger broadens keleya's service portfolio and also consolidates partnerships with 65 health insurance companies, covering about 65% of insured persons in Germany. This merger is poised to significantly impact the FemTech market by extending accessible, expert-led maternal care to a broader audience. [Published On: 2024-05-02]
Launch of Femtech Canada Marks a Milestone in Women's Health Innovation
Femtech Canada, a pioneering women's health network initiative by Innovation Factory, officially launched in Toronto, Ontario, devoted to women's health innovation, commercialization, and investment. The initiative aims to serve the health and wellness needs of women, girls, non-binary individuals, trans people, and those assigned female at birth, promoting a more inclusive healthcare environment. [Published On: 2024-02-01]
Strategic Merger to Propel Growth in Swedish Femtech Market
Peptonic, known for its medical treatments and lifestyle products, and Pharmiva, currently launching Vernivia for bacterial vaginosis treatment, have announced plans to merge to enhance both companies' market positioning and product offerings. The merger, expected to foster growth and expansion into new markets, must be approved by both companies' boards and an extraordinary general meeting in Pharmiva. [Published On: 2023-06-19]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Femtech Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Femtech Market, highlighting leading vendors and their innovative profiles. These include Allara Health, Apple Inc., Athena Feminine Technologies, Athena Feminine Technologies, Inc., AVA Sciences by FemTech Health, Bloomlife, Canopie Inc., Carrot Fertility, Inc., Chiaro Technology Limited, Chorus Health Inc., Cleo Labs, Inc., Clue by Biowink GmbH, Elektra Health, Elvie, Everlywell, Inc., Fitbit LLC by Google, Inc., Flo Health UK Limited, Flo Health, Inc., FOLX Health, Inc., Future Family, Inc., Garmin Ltd., Glow Inc., HeraMED, INTIMINA, iSono Health, Kindbody, Koninklijke Philips N.V., Maven Clinic Co., Natural Cycles USA Corp, NextGen Jane, NUROKOR Ltd., Nuvo Cares, Nuvo Group Ltd., Organon & Co., Renovia Inc., Rosy Wellness, Inc., Rume Medical Group, Inc., Samsung Electronics Co., Ltd., Sera Prognostics, Thirty Madison company, Tia, Inc., Unified Women's Healthcare, Univfy Inc., Willow Innovations, Inc., and Wolomi.
Market Segmentation & Coverage